NCT05337124View on ClinicalTrials.gov

A Prospective Observational Registry of Patients Treated With LUPKYNIS® (Voclosporin) in the US

CompletedOBSERVATIONAL
Enrollment

229

Participants

Timeline

Start Date

April 5, 2022

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions
Lupus Nephritis
Interventions
DRUG

LUPKYNIS

LUPKYNIS treatment per the approved US Prescribing Information

Trial Locations (1)

90280

Site 00-05, South Gate

Sponsors
All Listed Sponsors
collaborator

United BioSource, LLC

INDUSTRY

lead

Aurinia Pharmaceuticals Inc.

INDUSTRY